Bariatric Surgery clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
Sorry, in progress, not accepting new patients
Bariatric surgery leads to bone loss and increases fracture risk. This study evaluates whether denosumab can prevent the high-turnover bone loss that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
San Francisco, California and other locations
Our lead scientists for Bariatric Surgery research studies include Anne Schafer.
Last updated: